agilon health Inc
NYSE:AGL
agilon health Inc (NYSE:AGL)
Income Statement
1.2B
Revenue
| 1 Year |
53%
|
| 3 Years |
N/A
|
| 5 Years |
N/A
|
197M
Gross Proft
| 1 Year |
185%
|
| 3 Years |
N/A
|
| 5 Years |
N/A
|
-56.7M
Operating Income
| 1 Year |
47%
|
| 3 Years |
N/A
|
| 5 Years |
N/A
|
-60.1M
Net Income
| 1 Year |
79%
|
| 3 Years |
N/A
|
| 5 Years |
N/A
|
Currency: USD
| Dec-2020 | Dec-2019 | ||
|---|---|---|---|
| Revenue | |||
| Revenue |
1 218
+53%
|
794
-
|
|
| Gross Profit | |||
| Cost of Revenue |
(1 022)
|
(725)
|
|
| Gross Profit |
197
+185%
|
69
-
|
|
| Operating Income | |||
| Operating Expenses |
(253)
|
(176)
|
|
| Selling, General & Administrative |
(240)
|
(163)
|
|
| Depreciation & Amortization |
(14)
|
(12)
|
|
| Operating Income |
(57)
+47%
|
(107)
-
|
|
| Pre-Tax Income | |||
| Interest Income Expense |
(8)
|
(9)
|
|
| Total Other Income |
3
|
1
|
|
| Pre-Tax Income |
(62)
+46%
|
(115)
-
|
|
| Net Income | |||
| Tax Provision |
(1)
|
0
|
|
| Income from Continuing Operations |
(63)
|
(115)
|
|
| Net Income (Common) |
(60)
+79%
|
(283)
-
|
|
Balance Sheet
446M
Assets
| 1 Year |
11%
|
| 3 Years |
N/A
|
| 5 Years |
N/A
|
422M
Liabilities
| 1 Year |
19%
|
| 3 Years |
N/A
|
| 5 Years |
N/A
|
24.8M
Equity
| 1 Year |
-49%
|
| 3 Years |
N/A
|
| 5 Years |
N/A
|
Currency: USD
| Dec-2020 | Dec-2019 | ||
|---|---|---|---|
| Assets | |||
| Cash & Cash Equivalents |
107
|
124
|
|
| Cash Equivalents |
107
|
124
|
|
| Total Receivables |
145
|
93
|
|
| Accounts Receivables |
145
|
93
|
|
| Other Receivables |
0
|
0
|
|
| Other Current Assets |
43
|
29
|
|
| Total Current Assets |
294
|
246
|
|
| PP&E Net |
16
|
19
|
|
| PP&E Gross |
16
|
19
|
|
| Accumulated Depreciation |
7
|
5
|
|
| Intangible Assets |
61
|
71
|
|
| Other Long-Term Assets |
34
|
26
|
|
| Other Assets |
42
|
42
|
|
| Total Assets |
446
+11%
|
403
-
|
|
| Liabilities | |||
| Short-Term Debt |
0
|
0
|
|
| Current Portion of Long-Term Debt |
3
|
3
|
|
| Other Current Liabilities |
167
|
129
|
|
| Total Current Liabilities |
267
|
200
|
|
| Long-Term Debt |
65
|
67
|
|
| Other Liabilities |
90
|
87
|
|
| Total Liabilities |
422
+19%
|
354
-
|
|
| Equity | |||
| Common Stock |
312
|
284
|
|
| Retained Earnings |
551
|
491
|
|
| Additional Paid In Capital |
264
|
257
|
|
| Total Equity |
25
-49%
|
49
-
|
|
| Total Liabilities & Equity |
446
+11%
|
403
-
|
|
| Shares Outstanding | |||
| Common Shares Outstanding |
384M
|
384M
|
|
Cash Flow Statement
-53.2M
Operating Cash Flow
| 1 Year |
49%
|
| 3 Years |
N/A
|
| 5 Years |
N/A
|
-2.4M
Capital Expenditures
| 1 Year |
40%
|
| 3 Years |
N/A
|
| 5 Years |
N/A
|
-55.6M
Free Cash Flow
| 1 Year |
48%
|
| 3 Years |
N/A
|
| 5 Years |
N/A
|
Currency: USD
| Dec-2020 | Dec-2019 | ||
|---|---|---|---|
| Operating Cash Flow | |||
| Net Income |
(60)
|
(283)
|
|
| Depreciation & Amortization |
14
|
41
|
|
| Change in Deffered Taxes |
(3)
|
(16)
|
|
| Other Non-Cash Items |
(11)
|
120
|
|
| Cash Taxes Paid |
0
|
0
|
|
| Cash Interest Paid |
7
|
8
|
|
| Change in Working Capital |
6
|
33
|
|
| Cash from Operating Activities |
(53)
+49%
|
(104)
-
|
|
| Investing Cash Flow | |||
| Capital Expenditures |
(2)
|
(4)
|
|
| Other Items |
24
|
(1)
|
|
| Cash from Investing Activities |
22
-
|
(5)
-
|
|
| Financing Cash Flow | |||
| Net Issuance of Common Stock |
28
|
180
|
|
| Net Issuance of Debt |
(3)
|
(4)
|
|
| Other |
0
|
(0)
|
|
| Cash from Financing Activities |
25
-86%
|
176
-
|
|
| Change in Cash | |||
| Net Change in Cash |
(7)
-
|
67
-
|
|